Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will make the medicines available to more patients.. Under the new option ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

Health insurer Cigna announced a new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs. The deal caps copays at $200 a month through employer healthcare programs.

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients; The company hopes the new discount, which caps monthly out-of-pocket ...

In 2021, the median price was $180,000 for the 30 drugs first marketed through mid-July, according to a study published in JAMA. The median launch price was $300,000 in 2023 and $222,000 in 2022.

Continuing high prices and demand for GLP-1 weight-loss drugs is creating lots of questions about the affordability of these drugs for U.S. healthcare consumers. For more than two years, drugs ...

Health insurer Cigna announced a new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs. The deal caps copays at $200 a month through employer healthcare programs.

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients; The company hopes the new discount, which caps monthly out-of-pocket ...

Top of the morning to you. Gray skies are once again hovering over the soggy Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the ...

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients; The company hopes the new discount, which caps monthly out-of-pocket ...

"This solution is really focused towards clients that aren't covering it today, and what it allows us to do is one, to bring it on at a reduced price for the plan sponsor, but also capping out the ...